Delivery Order SPE2DB20D1051-SPE2DB23FD8UD
Award Date 7/28/23
Potential Completion Date 7/31/23
Potential Value $509
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $506,310 delivery order to Amerisourcebergen Drug Corporation for the provision of 60 units of 0.05% cyclosporine ophthalmic emulsion. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the drug to be delivered to a facility in Conshohocken, Pennsylvania by August 17, 2023. As the DLA supports military treatment facilities, this order is likely intended to stockpile the immunosuppressive...
- The Defense Logistics Agency awarded a $534 delivery order to Amerisourcebergen Drug Corporation for the supply of 30 units of 0.05% cyclosporine ophthalmic emulsion. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of the pharmaceutical products to a facility in Conshohocken, Pennsylvania by September 8, 2023. As the DLA supports all branches of the military, this order is likely intended to stockpile certain...
- The Defense Logistics Agency awarded a $1,250 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 30 units of 0.05% cyclosporine ophthalmic emulsion. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 2 to August 3, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military services and combatant...
- The Defense Logistics Agency awarded a $145 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 units of 0.05% cyclosporine ophthalmic emulsion. The single award was issued under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day in September 2023. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $3,878 delivery order to Amerisourcebergen Drug Corporation for 60 units of 0.05% cyclosporine ophthalmic emulsion. The contract has a firm fixed price and will be performed in Conshohocken, Pennsylvania over a one-day period from June 26-27, 2023. As a leading supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will deliver the requested cyclosporine eye emulsion to support the DLA's medical logistics...
- The Defense Logistics Agency awarded a $35,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 30 units of 0.05% cyclosporine ophthalmic emulsion. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order is for an immunosuppressive drug commonly used to treat ocular surface disease and was issued under an existing DLA contract vehicle. As a leading pharmaceutical distributor, Amerisourcebergen will deliver...
- The Defense Logistics Agency awarded a $3,995.88 delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30 units) with a completion date of September 18, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999...
- The Defense Logistics Agency Troop Support Medical awarded a $6,747.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for the supply of 30 units of 0.05% cyclosporine ophthalmic emulsion. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between June 28-29, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill this order to support the Defense Logistics...
- The Defense Logistics Agency awarded a $24,425.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30-count supply) on January 28, 2026, with an ultimate completion date of January 29, 2026. This non-set-aside contract will be performed in Conshohocken, Pennsylvania, where the contractor maintains its corporate office. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements through the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-count units, valued at $3,558.39. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award eligibility. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order represents a child contract...
Teaming
Find teaming partners for this award
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB23FD8UDDelivery Order
The Defense Logistics Agency awarded a $509 delivery order to Amerisourcebergen Drug Corporation to supply 4561636937 units of 0.05% cyclosporine ophthalmic emulsion. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for Amerisourcebergen to deliver the ophthalmic solution from its facility in Conshohocken, Pennsylvania by July 31, 2023 on a firm-fixed-price basis. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order will support the DLA's mission to provide critical medicines to military treatment facilities and beneficiaries.
Generated 12/24/23, 2:48 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $509 | 7/28/23 |